Study Group | ANA* | Anti-dsDNA | ASMA | F-actin | anti-TPO |
VL patients | 1/62 | 0/62 | 31/62 | 46/62 | 0/62 |
(n = 62) | (1.6%) | (0%) | (50%) | (74.2%) | (0%) |
p = | 0.5 | 0.5 | 0.00000003 | 0.0000001 | ____ |
PKDL patients | 11/31 | 5/31 | 13/31 | 20/31 | 0/31 |
(n = 31) | 35% | 16% | 42% | 64.5% | ____ |
p = | 0.0000001 | 0.02 | 0.00000003 | 0.00000001 | ____ |
Apparently Healthy | 2/62 | 1/62 | 4/62 | 4/62 | 0/62 |
(n = 62) | (3.3%) | (1.7%) | (6.6%) | (6.6%) | _____ |